tbuckley/cabot-search huggingface dataset:
Patients with Waldenstrom's Macroglobulinemia Are Often Hypoferremic That Is Refractory to Oral Iron Repletion and Responsive to Parental Iron Infusions, and Demonstrate Elevated Levels of Hepcidin.
Authors: Bryan Ciccarelli, Christopher J Patterson, Zachary Hunter, Christina Hanzis, Thea Ioakimidis, Robert Manning, Guang Yang, Ping Gong, Lian Xu, Yangsheng Zhou, Jenny Sun, Xia Liu, Hsiuyi Tseng, Yang Cao, Patricia Sheehy, Steven Treon
Journal: Blood (2009)
TXA plus compression and nasal packing did not differ for epistaxis, and both were better than compression alone
Authors: Shahriar Zehtabchi
Journal: Annals of Internal Medicine (2019)

Source Citation Akkan S, Corbacioglu SK, Aytar H, et al. Evaluating effectiveness of nasal compression with tranexamic acid compared with simple nasal compression and Merocel packing: a randomized ...
2% of Healthy Newborns Reveal ETV6-RUNX1 Fusion By Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL)
Authors: Daniel Schaefer, Marianne Olsen, Ulrik Lausten-Thomsen, Cyrill Schipp, Martin Stanulla, Robert K. Slany, Kjeld Schmiegelow, Arndt Borkhardt, Ute Fischer
Journal: Blood (2016)
Evaluation of the Diagnostic Utility of Cerebral Spinal Fluid (CSF) Flow Cytometry (FC) In Detection of Central Nervous System (CNS) Involvement by Hematological Malignancy.
Authors: Alaa Muslimani, Sani Kizilbash, Ishmael Jaiyesimi, Laura Nadeau, Dana Zakalik, Jeffery Margolis, James Huang
Journal: Blood (2010)
Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome
Authors: Joshua D. Bernstock, Arthur H. Totten, Abdel G. Elkahloun, Kory R. Johnson, Anna C. Hurst, Frederick Goldman, Andrew K. Groves, Fady M. Mikhail, T. Prescott Atkinson
Journal: Journal of Allergy and Clinical Immunology (2019)
Relapse in Childhood “Very High Risk” Acute Lymphoblastic Leukemia Treated with BFM Chemotherapy Has a Dismal Outcome Even When Treated with Transplantation.
Authors: Adriana Balduzzi, Maria Grazia Valsecchi, André Schrauder, Daniela Silvestri, Barbara Buldini, Arend von Stackelberg, Anna Maria Testi, Thomas Klingebiel, Christina Peters, Carmelo Rizzari, Elena Barisone, Martin Schrappe
Journal: Blood (2008)
Seroprevalence of Lyme borreliosis in Finland 50 years ago
Authors: J. Cuellar, T. Dub, J. Sane, J. Hytönen
Journal: Clinical Microbiology and Infection (2019)

Lyme borreliosis (LB) is a tick-borne infection common in Europe. In Finland, the LB seroprevalence in the healthy population was 3.9% in 2011. While the present-day seroprevalence of LB is well characterized in several European areas, there are no studies on the seroprevalence of LB before the description of the infection in the late 1970s.We used a subset of historical serum samples (n = 994) collected during the Finnish Mobile Clinic Health Survey, a nationwide cross-sectional health survey of the 1960s and 1970s. All samples were screened with Borrelia burgdorferi whole-cell sonicate IgG ELISA. The seropositivity of the samples was further confirmed by the C6 peptide ELISA and recomBead IgG 2.0 bead immunoassay. The association of LB seropositivity with risk factors and with self-reported diseases and symptoms relating to disseminated LB were analysed by logistic regression.B. burgdorferi IgGs were detected in 199 of 994 analysed samples; hence, the overall seroprevalence was 20.0% (95% confidence interval: 17.6-22.6). The highest seroprevalence was observed in persons aged ≥50 years (165/696), in those currently not working (92/383), and in the regions of South and Central Finland (91/226 and 27/88, respectively). Further, perception of feeling unhealthy (129/197 versus 412/794) was higher among LB-seropositive individuals compared to LB-seronegative participants.LB seroprevalence was considerably higher in Finland in the late 1960s and early 1970s than in 2011. This result questions the perception of an unprecedentedly high LB seroprevalence in present-day Europe.
Integrating Genetic Risk Factors with Age, Presenting White Cell Count and MRD Response As Continuous Variables to Predict Relapse in Paediatric Acute Lymphoblastic Leukemia (ALL)
Authors: Anthony V. Moorman, Amir Enshaei, David O'Connor, Jack Bartram, Jeremy Hancock, Christine Harrison, Sujith Samarasinghe, John Moppett, Ajay J. Vora, Nicholas Goulden
Journal: Blood (2016)
Multiple personality disorder among female inpatients in a state hospital
Authors: T T Latz, S I Kramer, D L Hughes
Journal: American Journal of Psychiatry (1995)

Professional skepticism and concerns regarding diagnostic reliability hinder research in dissociative disorders and multiple personality disorder. The reported frequency of multiple personality disorder in different psychiatric settings ranges from 2.4% to 35%. The authors conducted a replication study of multiple personality disorder ascertainment in women admitted to a state hospital over a 5.5-month period.Responses to the Dissociative Experiences Scale and to the Dissociative Disorders Interview Schedule were obtained, along with data on length of stay, county of admission referral, admission commitment status, and discharge diagnoses, for 176 female inpatients in a state hospital. Of 421 women representing 483 consecutive admissions, 121 were discharged before they could be assessed for study, 64 were excluded, 60 declined to participate, 176 enrolled in the study, and 175 completed the research procedures.Twenty-one women (12%) met criteria for multiple personality disorder based on the Dissociative Disorders Interview Schedule; these women were significantly younger than the women without multiple personality disorder. Scores on the Dissociative Experiences Scale of the women with multiple personality disorder (mean = 59.5, SD = 19.6) were significantly higher than the scores of women without multiple personality disorder (mean = 22.5, SD = 20.1), but considerable overlap occurred. There was no significant difference between groups in length of stay or admission status.The authors conclude that 1) the wide variability in multiple personality disorder detection is partially due to site-specific ascertainment biases and 2) despite its apparent usefulness for screening purposes, the Dissociative Experiences Scale requires more comprehensive evaluation before it can be applied broadly.
Large Genomic Aberrations Are Independent Prognosticators of A Shorter Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia (CLL) Patients with A Normal FISH
Authors: Michael Mian, Andrea Rinaldi, Afua Adjeiwaa Mensah, Davide Rossi, Marco Ladetto, Francesco Forconi, Roberto Marasca, Mario Uhr, Georg Stussi, Ivo Kwee, Franco Cavalli, Gianluca Gaidano, Emanuele Zucca, Francesco Bertoni
Journal: Blood (2012)
Racial Disparities in Patients with Myelodysplastic Syndrome (MDS): Clinical and Molecular Depiction
Authors: Hanadi Ramadan, Megan Melody, Amanda Steele, Najla H Al Ali, Eric Padron, David Sallman, Kendra L. Sweet, Jeffrey E. Lancet, Alan F List, Rami S. Komrokji
Journal: Blood (2016)
Minimal Residual Disease Stratification in Fludarabine Ccyclophosphamide Rituximab (FCR) Therapy in Chronic Lymphocytic Leukaemia (CLL
Authors: Amjad Hayat, David O'Brien, Fiona Quinn, Fionnuala Keane, Imelda Parker, Johanna Kelly, Marzena Wieczorkowska, Gerard Crotty, Maeve Leahy, Helen Enright, Brian Hennessy, Mary Cahill, Elisabeth A. Vandenberghe
Journal: Blood (2012)
cDNA Microarray Analysis of Genes Associated with NPM-ALK Overexpression in Anaplastic Large Cell Lymphomas.
Authors: Megan S. Lim4, G. Christopher Fillmore4, Stephen D. Jenson4, Richard A. Friedman, Jonathan A. Schumacher4, Sherrie L. Perkins4, George Z. Rassidakis, L. Jeffrey Medeiros, Mitchell S. Cairo, Kojo S.J. Elenitoba-Johnson4
Journal: Blood (2004)
Impact of Vitamin D Level After Allogeneic Hematopoietic Stem Cell Transplant
Authors: Lisa Sproat, Jane Olsen, Kristen Beebe, Rochelle Chiffelle, Susan Gerber, Brooke Loewen, Jane Palmer, Angela Toro, Roberta Adams, Veena Devi Salem Fauble, Nandita Khera, Jose Leis, Craig Reeder, James L Slack, Pierre Noel
Journal: Blood (2012)
Post-Autotransplant Hepatitis B Virus (HBV) Reactivation in Lymphoma and Multiple Myeloma Patients with Hepatitis B Surface Antigen-Positive or Resolved HBV Infection
Authors: Jieun Jang, Hyunsung Park, Jungyeon Lee, Yundeok Kim, Soo Jeong Kim, June-Won Cheong, Yoo Hong Min, Jin Seok Kim
Journal: Blood (2014)
Checkpoint Blockade for Treatment of Relapsed Lymphoma Following Allogeneic Hematopoietic Cell Transplant: Use May be Complicated By Onset of Severe Acute Graft Versus Host Disease
Authors: Bradley M. Haverkos, Jeffrey Schowinksy, Jeffrey Kaplan, Manali Kamdar, Abraham Sebastian Kanate, Ayman Saad, Amitkumar Mehta, Siddhartha Ganguly, Mary E.D. Flowers, Timothy S. Fenske, Parameswaran Hari, Mehdi Hamadani, Robert Lowsky, Leslie Andritsos, Madan H. Jagasia, Stacey Brown, Philippe Armand, Reid W. Merryman, Veronika Bachanova, Deborah M Stephens, Ryotaro Nakamura, Jonathan A Gutman, Steven M. Devine
Journal: Blood (2016)
BPI A645G SNP but Not NOD2 Genotype Predicts for Acute Lung Injury After Allogeneic Stem Cell Transplantation
Authors: Martin Wermke, Stefanie Maiwald, Christian Thiede, Johannes Schetelig, Gerhard Ehninger, Uwe Platzbecker, Martin Bornhäuser, Ralf Wassmuth
Journal: Blood (2010)
Multicenter, Randomized, Phase III Study Comparing Imatinib (Glivec) Standard Dose (400 mg/d) with Imatinib High Dose Induction (800 mg/d) Followed by Imatinib Maintenance (400 mg/d) in Patients with Pretreated Ph+/BCR-ABL+ CML in Chronic Phase - Results from the First Planned Interim Analysis (CELSG-CML 11 ISTAHIT Study).
Authors: Andreas L. Petzer, Dominik Wolf, Dominik Fong, Thomas Lion, Irina Dyagil, Zvenyslava Masliak, Darinka Boskovic, Laimonas Griskevicius, Sandra Lejniece, Emil Spasov, Liana Gercheva, Aleksandar Stojanovic, Dontcho Peytchev, Nikolay Tzvetkov, Rasa Griniute, Atanas Stanchev, Martin Kwakkelstein, Hanno Ulmer, Guenther A. Gastl
Journal: Blood (2007)
Preoperative Diagnostic Categories of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Thyroid Core Needle Biopsy and Its Impact on Risk of Malignancy
Authors: Hee Young Na, Ji Won Woo, Jae Hoon Moon, June Young Choi, Woo-Jin Jeong, Yeo Koon Kim, Ji-Young Choe, So Yeon Park
Journal: Endocrine Pathology (2019)
TET2 Mutations In Acute Myeloid Leukemia (AML): Results on 783 Patients Treated within the AML HD98A Study of the AML Study Group (AMLSG)
Authors: Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka, Claus-Henning Köhne, Gerhard Held, Marianne Habdank, Juliane Gohlke, Hans-Günther Mergenthaler, Hans J. Salwender, Lars Bullinger, Hartmut Döhner, Konstanze Döhner
Journal: Blood (2010)
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following Intensive Therapy and Autograft Correlates with the Type of Cells Grafted: A Survey on 1,347 Lymphoma Patients Receiving the High-Dose Sequential (HDS) Program.
Authors: Manuela Zanni, Michele Magni, Alessandro Rambaldi, Fabio Benedetti, Roberto Passera, Caterina Patti, Guido Parvis, Fabio Ciceri, Andrea Gallamini, Sergio Cortelazzo, Ignazio Majolino, Salvo Mirto, Paolo Corradini, Mario Boccadoro, Giuseppe Saglio, Giovanni Pizzolo, Tiziano Barbui, Alessandro M. Gianni, Corrado Tarella
Journal: Blood (2007)
Endothelial Protective Properties of Low Molecular Weight Heparin (LMWH) Tinzaparin in Combination with Statin: A Novel Potential Therapeutic Tool in Preventing Cancer Metastasis?
Authors: Barry Kevane, Karl Egan, Seamus Allen, Patricia Maguire, Elaine Neary, Áine Lennon, Fionnuala Ní Áinle
Journal: Blood (2016)
Non-invasive in vivo imaging of caspase-1 activation enables rapid and spatiotemporal detection of acute and chronic inflammatory disorders
Authors: Young Ji Ko, Jae-Won Lee, Eun-Jeong Yang, Nayoon Jang, Jooho Park, Yoon Kyung Jeon, Je-Wook Yu, Nam-Hyuk Cho, Hye-Sun Kim, Ick Chan Kwon
Journal: Biomaterials (2019)

Inflammasome plays a critical role in diverse inflammatory disorders, including cancers and Alzheimer's disease. It is induced by various pathogenic insults and activates caspase-1, a hallmark executor of inflammasome. Here, we developed an activatable fluorescence probe for visualization of active caspase-1. This caspase-1 probe is biocompatible, efficiently delivered into cells and tissues, and specifically emits fluorescence upon caspase-1 activation as assessed in in vitro and in vivo models of inflammatory conditions. We demonstrated efficient in vivo imaging of caspase-1 activation in early stages of various inflammatory conditions of mice models, including endotoxin shock, inflammatory bowel disorder, transplanted cancer, and Alzheimer's disease. Notably, the caspase-1 probe enables detection of neuroinflammation in vivo two months earlier than cognitive impairments occur in Alzheimer's disease model. We detected significant fluorescence emitted from inflamed sites, as well as their draining lymph nodes, by macroscopic imaging analysis within 30 min after systemic injection of the probe. This novel synthetic probe could be applied for efficient and rapid detection of caspase-1 activity in a spatiotemporal way by non-invasive imaging.
In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent
Authors: Michele Baccarani, Ilaria Iacobucci, Sabina Chiaretti, Robin Foà’, Poonkuzhali Balasubramanian, Elisabeth Paietta, Letizia Foroni, Sabine Jeromin, Barbara Izzo, Orietta Spinelli, Neelam Varma, Samia Menif, Carolina Terragna, Tulika Seth, Audrey Bidet, Daniel Coriu, Francesca Lunghi, Jiri Mayer, Barbara Scappini, Stephen Langabeer, Jacqueline Maier, Emma Burt, Anna Candoni, Francesco Albano, Mario Luppi, Irena Zupan, Thomas Lion, Renata Zadro, Francesco di Raimondo, Behzad Poopak, Giovanna Rege-Cambrin, Mario Annunziata, Ana Ayala, Victor Salinas-Viedma, Ana Ines Prado, Benedict Milner, Sara Galimberti, Jeroen Janssen, Valentina Polli, Lorenzo Comba, Beatrice Borsellino, Ombretta Annibali, Monica Crugnola, Francesco Passamonti
Journal: Leukemia (2019)
Donor Lymphocyte Infusions Induce High Response Rates and Durable Salvage in Relapsed Hodgkin Lymphoma Post T Cell Depleted Allogeneic Transplantation.
Authors: Karl S Peggs, Kirsty Thomson, Emma Morris, Noha Chowdhry, Stephanie Verfuerth, Panos Kottaridis, Anthony H. Goldstone, Kirit Ardeshna, David Linch, Ronjon Chakraverty, Stephen Mackinnon
Journal: Blood (2009)
Additional Consolidation after Attaining Second Complete Remission Results in Superior Outcomes after Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia
Authors: Sara Lozano Cerrada, David Marin, Gabriela Rondon, Celina Ledesma, Uday R. Popat, Amanda Olson, Amin Alousi, Betul Oran, Sairah Ahmed, Stefan O. Ciurea, Krina Patel, Elizabeth J. Shpall, Chitra Hosing, Muzaffar H. Qazilbash, Nina Shah, Katy Rezvani, Elias Jabbour, Hagop M. Kantarjian, Richard E. Champlin, Partow Kebriaei
Journal: Blood (2016)
Impact of Charlson comorbidity index on survival in patients with diffuse large B-cell lymphoma who received R-CHOP
Authors: Atsushi Inagaki, Shigeru Kusumoto, Ayako Masaki, Yoshiaki Marumo, Takaki Kikuchi, Shiori Kinoshita, Fumiko Mori, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida
Journal: Annals of Oncology (2019)
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib
Authors: Sara Galimberti, Laura Galeotti, Francesco Ceccherini, Marialuisa Polillo, Claudia Baratè, Giulia Fontanelli, Francesca Guerrini, Roberta Arici, Sara Barsotti, Federica Ricci, Lara Aprile, Fulvio Cornolti, Mario Petrini, Monica Bocchia, Antonello Di Paolo
Journal: Blood (2014)
Identification of Alpha 1-Acid Glycoprotein (AAG) As a Potential Patient Selection Biomarker for Improved Clinical Activity of the Novel KSP Inhibitor ARRY-520 in Relapsed and Refractory Multiple Myeloma (MM)
Authors: Brian Tunquist, Karin Brown, Gary Hingorani, Sagar Lonial, Jonathan L. Kaufman, Jeffrey A. Zonder, Adam D Cohen, William I. Bensinger, Robert Z. Orlowski, Jatin J. Shah, Brandi Hilder, Ann Marie Ptaszynski, Kevin Koch, Kevin Litwiler, Duncan Walker
Journal: Blood (2012)
RELAY: Global Ph3 study of erlotinib + ramucirumab or placebo in metastatic NSCLC with EGFR mutation - East Asian subset
Authors: Makoto Nishio, Takashi Seto, Martin Reck, Edward B. Garon, Chao-Hua Chiu, Kiyotaka Yoh, Fumio Imamura, Keunchil Park, Jin-Yuan Shih, Carla Visseren-Grul, Bente Frimodt-Moller, Annamaria Zimmermann, Gosuke Homma, Sotaro Enatsu, Kazuhiko Nakagawa
Journal: Annals of Oncology (2019)
ARTS, a Pro-Apoptotic Mitochondrial Septin-Like Protein That Binds to XIAP, Is Silenced in Acute Lymphoblastic and Primitive Acute Myeloblastic Leukemia Cells.
Authors: Masato Shikami, Marina Konopleva, Ismael Samudio, Koyu Hoshino, Guillermo Garcia-Manero, Kensuke Kojima, Twee Tsao, Teresa McQueen, Michael Andreeff
Journal: Blood (2004)
BCR/ABL+ CML Stem Cells (CD34+/CD38-) Express High Levels of CD33 and Are Responsive to a CD33-Targeting Drug: a New Potential Concept for Eradication of CML Stem Cells.
Authors: Harald Herrmann, Sabine Cerny-Reiterer, Karoline V. Gleixner, Katharina Blatt, Susanne Herndlhofer, Hermine Agis, Werner Rabitsch, Berthold Streubel, Gerlinde Mitterbauer-Hohendanner, Wolfgang R. Sperr, Christian Sillaber, Peter Valent
Journal: Blood (2010)
ACE-011, a Soluble Activin Receptor Type Iia IgG-Fc Fusion Protein, Increases Hemoglobin (Hb) and Improves Bone Lesions in Multiple Myeloma Patients Receiving Myelosuppressive Chemotherapy: Preliminary Analysis.
Authors: Kudrat M. Abdulkadyrov, Galina N. Salogub, Nuriet K. Khuazheva, Rachel Woolf, Eric Haltom, Niels G. Borgstein, Robert Knight, Gary Renshaw, Yijun Yang, Matthew L. Sherman
Journal: Blood (2009)
Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) Concentrates Vincristine in Tumor Tissue and Lymphoid Malignancy Oriented Tissues in Tumor-Bearing Mice.
Authors: Pieter R. Cullis, Hagop Kantarjian, Frederick Appelbaum, Susan O’Brien, May Wong, Gavin S. Choy, Steven R. Deitcher
Journal: Blood (2007)
Targeting JAK2 By Gene Knockout or Pacritinib Treatment Reduces Gvhd and Xenograft Rejection By Promoting Induced Treg Differentiation
Authors: Brian C Betts, David Bastian, Hung Nguyen, Jessica Lauren Heinrichs, Yongxia Wu, Anandharaman Veerapathran, Marie C Lee, Jack Singer, Claudio Anasetti, Xue-Zhong Yu
Journal: Blood (2015)
I spy with my little eye … a knee about to go ‘pop’? Can coaches and sports medicine professionals predict who is at greater risk of ACL rupture?
Authors: Anne Inger Mørtvedt, Tron Krosshaug, Roald Bahr, Erich Petushek
Journal: British Journal of Sports Medicine (2019)

The vertical drop jump (VDJ) test is widely used for clinical assessment of ACL injury risk, but it is not clear whether such assessments are valid.To examine if sports medicine professionals and coaches are able to identify players at risk of sustaining an ACL injury by visually assessing player performance during a VDJ test.102 video clips of elite female handball and football players performing a baseline VDJ test were randomly extracted from a 738-person prospective cohort study that tracked ACL injuries. Of the sample, 20 of 102 went on to suffer an ACL injury. These 102 videos were uploaded to an online survey. Sports medicine professionals and coaches were invited to assess athlete performance and rate each clip with a number between 1 and 10 (1 representing low risk of sustaining an ACL injury and 10 representing high risk). Receiver operating characteristic analyses were used to assess classification accuracy and between-group differences were analysed using one-way analysis of variance.237 assessors completed the survey. Area under the curve values ranged from 0.36 to 0.60, with a mean score of 0.47, which is similar to random guessing. There were no significant differences in classification accuracy between groups (physicians, coaches, certified athletic trainers, researchers or physical therapists).Assessors have poor predictive ability (no better than chance), indicating that visual assessment of a VDJ test is a poor test for assessing ACL injury risk in elite female handball and football players.
A Genome-Wide Analysis of Variants Influencing Methotrexate Clearance Replicates SLCO1B1.
Authors: Laura B. Ramsey, John C Panetta, Colton Smith, Wenjian Yang, Yiping Fan, Naomi Winick, Paul L. Martin, Cheng Cheng, Meenakshi Devidas, Ching-Hon Pui, William E. Evans, Stephen P. Hunger, Mignon L. Loh, Mary V. Relling
Journal: Blood (2012)
Analysis of Parameters Predicting Treatment Efficacy and Outcome In Patients with Hairy Cell Leukemia (HCL) Receiving Subcutaneous Cladribine In the ICGHCL2004 Protocol (by the Italian Cooperative Group on HCL)
Authors: Francesco Forconi, Emanuele Cencini, Francesco Zaja, Tamara Intermesoli, Francesca Fiore, Benedetta Puccini, Caterina Stelitano, Renato Cantaffa, Alessandro Pulsoni, Alfonso Zaccaria, Pier Luigi Zinzani, Andrea Piccin, Filippo Gherlinzoni, Alessandro Levis, Giovanni Martinelli, Sara Barulli, Fortunato Morabito, Ivana Pierri, Miriana Ruggeri, Alessandra Caremani, Luciano Masini, Giuseppe Polimeno, Angelo Guerrasio, Elisa Sozzi, Davide Rossi, Francesco Bertoni, Piero Galieni, Marco Gobbi, Sergio Cortelazzo, Luigi Rigacci, Andrea Gallamini, Robin Foà, Francesco Lauria
Journal: Blood (2010)
The Use of Chemoimmunotherapy Improves the Outcome of Patients with Chronic Lymphocytic Leukaemia (CLL) – a Metaanalysis of Five Trials of the German CLL Study Group (GCLLSG)
Authors: Paula Cramer, Susanne Isfort, Jasmin Bahlo, Raymonde Busch, Petra Langerbeins, Anna-Maria Fink, Valentin Goede, Thomas Elter, Manuela A. Bergmann, Martina Beate Stauch, Stephan Stilgenbauer, Clemens-Martin Wendtner, Kirsten Fischer, Michael Hallek, Barbara F. Eichhorst
Journal: Blood (2012)
The Efficient Engraftment of Human Hematopoiesis in the Balb/c Strain Is Mounted by Balb/c-Specific SIRPA Polymorphism That Enhances Binding Affinity to Human CD47,
Authors: Chika Iwamoto, Katsuto Takenaka, Shingo Urata, Takahiro Shima, Katsuhiko Itoh, Junji Kishimoto, Toshihiro Miyamoto, Takashi Matozaki, Koichi Akashi
Journal: Blood (2011)
Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation.
Authors: Loredana Ruggeri, Emanuela Burchielli, Katia Perruccio, Marusca Capanni, Martin Stern, Kathrin Hafen, Franco Aversa, Massimo F. Martelli, Luigina Romani, George Hollander, Andrea Velardi
Journal: Blood (2006)
Relationship between CD33 Expression, P-Glycoprotein-Mediated Drug Efflux, and Clinical Outcome in Patients Treated in Phase II Trials with Gemtuzumab Ozogamicin Monotherapy.
Authors: Roland B. Walter, Ted A. Gooley, Vincent H.J. van der Velden, Michael R. Loken, Jacques J.M. van Dongen, Irwin D. Bernstein, Frederick R. Appelbaum
Journal: Blood (2006)
The Novel Technique of Genetically Engineered Patient-Derived Xenografts (GEPDX) Reveals That the X-Linked Inhibitor of Apoptosis Protein (XIAP) Plays an Essential Role for Maintenance and Growth of Patients' Acute Lymphoblastic Leukemia In Vivo
Authors: Michela Carlet, Jenny Vergalli, Cornelia Finkenzeller, Michaela Grunert, Irmela Jeremias
Journal: Blood (2015)
Two-Pronged Cell Therapy for B-Cell Malignancies: Engineering NK Cells to Target CD22 and Redirect Bystander T Cells to CD19
Authors: Mireya Paulina Velasquez, Arpad Szoor, Challice L. Bonifant, Abishek Vaidya, Lorenzo Brunetti, Michael C Gundry, Robin Parihar, Margaret Goodell, Stephen Gottschalk
Journal: Blood (2016)
Soluble Inflammatory Mediators Proteinase-3 and Neutrophil Elastase Are Targeted by PR1-Specific Immunotherapy After Cellular Uptake and Cross Presentation of PR1 Peptide by Breast Cancer Cells
Authors: Gheath Alatrash, Elizabeth Mittendorf, Anna Sergeeva, Pariya Sukhumalchandra, Na Qiao, Kathryn Quintanilla, Mao Zhang, Lu Sijie, Karen Clise-Dwyer, Jeffrey J. Molldrem
Journal: Blood (2010)
SUNRISE-DI Study: Decision Impact of the 12-Gene RS Assay on Adjuvant Chemotherapy for Stage II and IIIA/B Colon Cancer
Authors: Koji Ando, Daisuke Kotani, Masataka Ikeda, Hideki Ueno, Takeshi Kato, Tetsuya Kusumoto, Toshiki Masuishi, Kensei Yamaguchi, Akiyoshi Kanazawa, Tomohiro Nishina, Hiroyuki Uetake, Mitsuyoshi Ota, Yoshinori Kagawa, Takeo Sato, Takeharu Yamanaka, Takayuki Yoshino
Journal: Annals of Oncology (2019)